23rd March 2021 Product update: Gold Standard Diagnostics
New RT-PCR Kit Detects Mutations in Most SARS-CoV-2 Variants of Concern
Eurofins Technologies has announced the launch of its GSD NovaType II, its upgraded RT-PCR kit for the identification of mutations associated with SARS-CoV-2 variants of concern.
The first GSD NovaType RT-PCR kit was launched in February 2021 and quickly supported health authorities in the detection of variants in more than 100,000 COVID-19 positive patients across Europe.
The new GSD NovaType II kit can now detect the N501Y and E484K mutations common to most VOC (Variants Of Concern) and the K417N mutation (specific to B.1.351 first identified in South Africa), with high sensitivity.
The GSD NovaType II kit delivers results in under two hours. It is therefore well suited to timely screening and relieving sequencing capacities for use in epidemiological studies.
Fast-paced screening for these emerging variants that may spread more easily, cause more severe disease, or may escape the body’s immune response even post-vaccination is a critical element to containing the pandemic.
Laboratories can use the GSD NovaType II SARS-CoV-2 kit to identify genomic mutations in extracted samples that have already been tested positive for the presence of SARS-CoV-2 RNA.
The GSD NovaType II SARS-CoV-2 kit contains specific primers and probes for amplification and simultaneous detection of specific RNA sequences which represent specific SARS-CoV-2 S gene variants.
It is delivered in a ready-to-use format with optional interpretation software. The assay has been validated on the AriaMx™ and AriaDx™ qPCR platforms from Agilent Technologies and will soon be validated on additional thermocyclers.
The assay is currently for Research Use Only (RUO), but the CE-IVD mark is expected shortly.
Eurofins Technologies is at the forefront of COVID-19 detection and is continuously monitoring the emergence of new SARS-CoV-2 variants of concern and developing new products to meet the rapidly evolving challenges.
For more details use the 'Request Information' button below.
Date Published: 23rd March 2021
Note: This content has been edited by a rapidmicrobiology staff writer for style and content.